Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

086900:KS

346,900 KRW 7,000 1.98%

As of 22:42:52 ET on 03/01/2015.

Snapshot for Medy-Tox Inc (086900)

Open: 357,700 Day's Range: 344,900 - 357,700 Volume: 27,123
Previous Close: 353,900 52wk Range: 112,400 - 417,500 1-Yr Rtn: +119.98%

Stock Chart for 086900

No chart data available.
  • 086900:KS 347,000
  • 1D
  • 1M
  • 1Y
353,900
Interactive 086900 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 086900

Current P/E Ratio (ttm) 45.2182
Estimated P/E(12/2015) 35.8782
Relative P/E vs. KOSPI 1.5391
Earnings Per Share (KRW) (ttm) 7,654.0000
Est. EPS (KRW) (12/2015) 9,646.5330
Est. PEG Ratio -
Market Cap (M KRW) 1,957,726.76
Shares Outstanding (M) 5.66
30 Day Average Volume 60,738
Price/Book (mrq) 22.6732
Price/Sale (ttm) 26.4045
Dividend Indicated Gross Yield 0.29%
Cash Dividend (KRW) 1,000.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 086900

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 086900

Medy-Tox Inc. is a biopharmaceutical company. The Company researches, develops and manufactures biopharmaceutical products using clostridium botulinum which is a microorganism toxin.

Jung Hyun-HoPresident/CEO/Rep DirectorYang Ki-HyukSenior Managing Director
Park Seung-BeomExecutive DirectorChoi Young-JinExecutive Director
More Company Profile & Key Executives for 086900

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil